Eric Sicard
Altasciences Company Inc. · Algorithme Pharma Inc · Clinical Research Unit
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
41
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers
24
PubMed author-name match
Trials
Studies that name Eric Sicard as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:46 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07118891 · Study Evaluating ABCL635 for Vasomotor Symptoms of MenopauseAbCellera Biologics Inc. · active not recruiting · Vasomotor Symptoms Associated With Menopause, Healthy Volunteers · principal investigator
- Ph1NCT07108894 · A First-in-Human Phase 1 Single-Ascending Dose Study of ABCL575 in Healthy ParticipantsAbCellera Biologics Inc. · active not recruiting · Healthy Volunteers · principal investigator
- Ph1NCT06787586 · Safety, Tolerability and PK of ATTO-1310 in Healthy Volunteers and Patients With Atopic Dermatitis and Patients With Chronic PruritusAttovia Therapeutics Inc · completed · Normal Volunteers, Atopic Dermatitis (AD), Atopic Eczema · principal investigator
- Ph1NCT05549583 · Comparative Bioavailability Study of Sitagliptin/Metformin 50 mg/1000 mg Tablets in Healthy Male and Female VolunteersGalenicum Health · completed · Bioequivalence, Type 2 Diabetes · principal investigator
- Ph1NCT05549570 · Comparative Bioavailability Study of Metformin/Sitagliptin 850 mg/50 mg Tablets in Healthy Male and Female VolunteersGalenicum Health · completed · Bioequivalence, Diabetes Mellitus, Type 2 · principal investigator
- Ph1NCT05517486 · Single-dose to Evaluate the Pharmacokinetics of GTX-101 and Subcutaneous Injectable Bupivacaine in Healthy SubjectsGrace Therapeutics Inc. · unknown · Postherpetic Neuralgia · principal investigator
- Ph1NCT05418348 · Relative Bioavailability of Intravenous GTX-104 Compared to Oral Nimodipine Capsules in Healthy SubjectsGrace Therapeutics Inc. · completed · Aneurysmal Subarachnoid Hemorrhage · principal investigator
- Ph1/Ph2NCT05363293 · Multiple Ascending Dose Safety, Tolerability, PK Study of AL001 in Alzheimer's Disease Patients & Healthy Adult SubjectsAlzamend Neuro, Inc. · completed · Alzheimer's Disease, Healthy Non-elderly and Elderly Adults · principal investigator
- Ph1NCT05160090 · Single Dose Crossover Comparative Bioavailability Study of Bupropion Hcl MR Tablet 300mgAlembic Pharmaceuticals Ltd. · completed · Bioequivalence · principal investigator
- Ph1NCT05145608 · Comparative Bioavailability Study of Lamotrigine ER Tablets USP 50 mgAlembic Pharmaceuticals Ltd. · completed · Bioequivalence · principal investigator
- Ph1NCT05145621 · Oral Bio-equivalence StudyAlembic Pharmaceuticals Ltd. · completed · Bioequivalence, Safety · principal investigator
- Ph1NCT04623034 · Evaluation of the Safety and Pharmacokinetics of MSI-195 to a Commercial S-AdenosylmethionineMSI Methylation Sciences, Inc. · completed · Major Depressive Disorder · principal investigator
- Ph1NCT04138888 · A Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil/ Hydrochlorothiazide After a Single Oral Dose Administration Under Fasting ConditionsPharmtechnology LLC · unknown · Bioequivalence · principal investigator
- Ph1NCT04038008 · Single Dose Crossover Comparative Bioavailability Study of Two Formulations of Fluconazole 200 mg in Healthy Adult Subjects Under Fasting ConditionsPharmtechnology LLC · completed · Bioequivalence · principal investigator
- Ph1NCT04012307 · The Bioequivalence Study of Two Different Formulations of Candesartan Cilexetil After a Single Oral Dose Administration Under Fasting ConditionsPharmtechnology LLC · completed · Bioequivalence · principal investigator
- Ph1NCT03951051 · The Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil After a Single Oral Dose Administration Under Fasting Conditions.Pharmtechnology LLC · completed · Bioequivalence · principal investigator
- Ph1NCT03918551 · Bioequivalence Study of Two Formulations of Febuxostat 120 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose Administration Under Fasting ConditionsPharmtechnology LLC · completed · Bioequivalence · principal investigator
- Ph1NCT03915340 · Bioequivalence Study of Two Formulations of Propafenone 300 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose Administration Under Fasting ConditionsPharmtechnology LLC · completed · Bioequivalence · principal investigator
- Ph1NCT03772158 · Cetirizine Chewable Bioequivalence and Food Effect StudyJohnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division · completed · Allergy · principal investigator
- Ph1NCT03705533 · Bioequivalence Study of Two Formulations of Telmisartan 80 mg Tablets in Healthy Adult Volunteers Under Fasting StatePharmtechnology LLC · completed · Bioequivalence · principal investigator
- Ph1NCT02690727 · To Evaluate the Food Effect on Relative Bioavailability of RP6530 in Healthy VolunteersRhizen Pharmaceuticals SA · completed · Healthy · principal investigator
- Ph1NCT02465489 · Comparison of Deferiprone Extended Release Tablets and Ferriprox Immediate Release Tablets in Healthy VolunteersApoPharma · completed · Healthy · principal investigator
- Ph1NCT02276768 · Study on Analgesia of GIC-1001 & GIC-1002 on Visceral Pain, Rectal Sensory Threshold Using the Barostat Methodgicare Pharma Inc. · completed · Pain, Cancer, Colonic Disease · principal investigator
- Ph1NCT02071823 · Comparative Bioavailability Study of BIA 9-1067 25 mg CapsulesBial - Portela C S.A. · completed · Parkinson · principal investigator
- Ph1NCT01923558 · Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fasting ConditionDr. Reddy's Laboratories Limited, India · completed · Healthy · principal investigator
- Ph1NCT01923259 · Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fed ConditionDr. Reddy's Laboratories Limited, India · completed · Healthy · principal investigator
- Ph1NCT01738425 · A Clinical Phase I Study on GIC-1001 in Healthy Volunteersgicare Pharma Inc. · completed · Colonic Diseases · principal investigator
- Ph1NCT01533116 · Effect of BIA 9-1067 at Steady-state on the Pharmacokinetics of Levodopa/Carbidopa and Levodopa/BenserazideBial - Portela C S.A. · completed · Parkinson Disease · principal investigator
- Ph1NCT01533077 · Pharmacokinetic Interaction Between BIA 9-1067 and Standard-release Levodopa/CarbidopaBial - Portela C S.A. · completed · Parkinson Disease · principal investigator
- Ph1NCT01036854 · Pharmacokinetic Study of Ondansetron Administered as IR (Zofran) and MR (EUR1025)Forest Laboratories · completed · Nausea · principal investigator
- Ph1NCT00981487 · Bioavailability Study of Anti Nausea Medication With and Without Food (EUR-1025)Forest Laboratories · completed · Nausea · principal investigator
- Ph1NCT00905190 · Bioavailability Study of Anti Nausea Medication With and Without FoodForest Laboratories · completed · Nausea · principal investigator
- Ph1NCT00865085 · A Relative Bioavailability Study of Citalopram 40 mg Tablets Under Fasting ConditionsActavis Inc. · completed · Healthy · principal investigator
- Ph1NCT00864890 · A Relative Bioavailability Study of Citalopram 40 mg Tablets Under Fed ConditionsActavis Inc. · completed · Healthy · principal investigator
- Ph1NCT00839072 · Comparative Bioavailability Study of Extended-release and Immediate-release Trazodone in Healthy Adult VolunteersLabopharm Inc. · completed · Healthy · principal investigator
- Ph1NCT00684723 · Fed Bioavailability Study of Lovastatin Tablets and Mevacor TabletsMutual Pharmaceutical Company, Inc. · completed · Healthy · principal investigator
- Ph1NCT00659074 · Bioavailability Study of Ondansetron 24 mg Orally Disintegrating Tablets Under Fasting ConditionsPar Pharmaceutical, Inc. · completed · Healthy · principal investigator
- Ph1NCT00647738 · Comparative Bioavailability Study of Baclofen 20 mg Tablets in Healthy Male Volunteers / Fasting StateMylan Pharmaceuticals Inc · completed · Healthy · principal investigator
- Ph1NCT00648960 · Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fasting StateMylan Pharmaceuticals Inc · completed · Healthy · principal investigator
- Ph1NCT00648128 · Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fed StateMylan Pharmaceuticals Inc · completed · Healthy · principal investigator
- Ph1NCT00648830 · Comparative Bioavailability Study of Clarithromycin 250 mg TabletsMylan Pharmaceuticals Inc · completed · Healthy · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:46 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:46 UTC. The ranking covers the 200 most relevant of 24 PubMed records, and a shared surname and initials can bring in a namesake. All 24 on PubMed
- The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection.J Hepatol · 2015171 citationsRCR 5.3
- Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection.J Hepatol · 2015169 citationsRCR 6.8
- A phase I study of irinotecan as a 3-week schedule in children with refractory or recurrent solid tumors.J Clin Oncol · 200380 citationsRCR 1.9
- Multicentre phase II study and pharmacokinetic analysis of irinotecan in chemotherapy-naïve patients with glioblastoma.Ann Oncol · 200371 citationsRCR 1.6
- Safety and pharmacokinetics of chimeric anti-Shiga toxin 1 and anti-Shiga toxin 2 monoclonal antibodies in healthy volunteers.Antimicrob Agents Chemother · 200966 citationsRCR 1.9
- Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study.Nat Med · 202262 citationsRCR 4.6
- The Oral β-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies.Antimicrob Agents Chemother · 201759 citationsRCR 2.5
- Single-dose pharmacokinetics of co-crystal of tramadol-celecoxib: Results of a four-way randomized open-label phase I clinical trial in healthy subjects.Br J Clin Pharmacol · 201733 citationsRCR 1.9
- Pharmacokinetic interaction study between eslicarbazepine acetate and lamotrigine in healthy subjects.Acta Neurol Scand · 201029 citationsRCR 1.2
- Pharmacokinetic bioequivalence, safety and acceptability of Ornibel®, a new polymer composition contraceptive vaginal ring (etonogestrel/ethinylestradiol 11.00/3.474 mg) compared with Nuvaring® (etonogestrel/ethinylestradiol 11.7/2.7 mg).Eur J Contracept Reprod Health Care · 201727 citationsRCR 1.6